Donepezil Reduces Severity of Down’s Syndrome-Related Dementia
NEW YORK (Reuters Health) Jul 29 – The acetylcholinesterase inhibitor donepezil, which improves symptoms of Alzheimer’s disease,
NEW YORK (Reuters Health) Jul 29 – The acetylcholinesterase inhibitor donepezil, which improves symptoms of Alzheimer’s disease,
LONDON (Reuters) Jul 26 The European Medicines Evaluation Agency said on Thursday GlaxoSmithKline’s anti-smoking drug Zyban had
WASHINGTON (Reuters Health) Jul 29 – US Food and Drug Administration (FDA) has approved an on-site assay
Different types of malformations of cortical development appear across a spectrum, and prompted by a complex mix
A post-hoc analysis comparing data from the SYST-EUR trial and the PROGRESS trial suggests that calcium-channel blockers
Preliminary analysis of data from the Swedish Twin Registry suggests that estrogen is neuroprotective and the effect
The benefits of galantamine (Reminyl) in slowing cognitive decline in Alzheimer’s disease appear to be sustained for
The use of either a selective or a non-selective nonsteroidal antiinflammatory drug for the treatment of Alzheimer’s
Unlike many antiepileptic drugs (AEDs) that alter the effectiveness of oral contraceptive pills (OCP), primarily through induction
Orphan Medical, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Xyrem® (sodium oxybate)
נא ציין כתובת דואר אלקטרוני שבה אתה מקבל דיוורי e-Med או זו שציינת בכרטיס האישי שלך.
קישור לאיפוס סיסמא נשלח למייל.
חזרה להתחברות